Today's Daily Dose brings you news about Karyopharm's BOSTON study; Synergy Pharma's upcoming regulatory catalyst related to Trulance; FDA panel review of ABP 215, a biosimilar candidate to Roche's Avastin; TEVA's HALO study and AbbVie's SELECT-NEXT study.
from RTT - Biotech http://ift.tt/2sW20vZ
via IFTTT
No comments:
Post a Comment